Sandrock Alfred Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
31
Insider Sells Sum
$26.96M

Insider Activity of Sandrock Alfred

According to the SEC Form 4 filings, Sandrock Alfred, being in a position of

  1. President and CEO at Voyager Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 49632 shares for $184,446,
    over all time since 2023-04-03, has bought 0 shares, and sold 121448 shares for $620,376.

Biography of Sandrock Alfred

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $184,4464100

Comparison of Insiders on Amount of Buys and Sells

2026-04-02SaleVoyager Therapeutics, Inc.
VYGR
President and CEO
11,511
0.0187%
$3.87$44,548-14.02%
2026-02-24SaleVoyager Therapeutics, Inc.
VYGR
President and CEO
14,197
0.0256%
$3.79$53,807-7.41%
2026-02-18SaleVoyager Therapeutics, Inc.
VYGR
President and CEO
11,732
0.0215%
$3.41$40,006+4.79%
2026-02-10SaleVoyager Therapeutics, Inc.
VYGR
President and CEO
12,192
0.0224%
$3.78$46,086-5.41%
2025-04-02SaleVoyager Therapeutics, Inc.
VYGR
President and CEO
10,885
0.0198%
$3.43$37,336+12.61%
2025-02-20SaleVoyager Therapeutics, Inc.
VYGR
President and CEO
11,702
0.0211%
$4.24$49,616-11.5%
2025-02-11SaleVoyager Therapeutics, Inc.
VYGR
President & CEO
16,644
0.0255%
$4.45$74,066-7.84%
2024-04-02SaleVoyager Therapeutics, Inc.
VYGR
President and CEO
12,115
0.0222%
$9.86$119,454-33.1%
2024-02-21SaleVoyager Therapeutics, Inc.
VYGR
President and CEO
13,033
0.0278%
$7.46$97,226-7.33%
2023-04-03SaleVoyager Therapeutics, Inc.
VYGR
President and CEO
7,437
0.0187%
$7.83$58,232+2.46%
2021-06-07SaleBiogen Inc.
BIIB
Head of Research & Development
7,672
0.0057%
$440.00$3.38M-39.39%
2020-11-04SaleBiogen Inc.
BIIB
EVP, Research & Development
3,000
0.0018%
$350.00$1.05M-22.4%
2018-02-27SaleBiogen Inc.
BIIB
EVP, Chief Medical Officer
518
0.0002%
$290.83$150,650+10.13%
2018-02-23SaleBiogen Inc.
BIIB
EVP, Chief Medical Officer
1,816
0.0009%
$293.44$532,887+9.06%
2018-02-20SaleBiogen Inc.
BIIB
EVP, Chief Medical Officer
1,486
0.0007%
$292.00$433,912+10.94%
2018-02-15SaleBiogen Inc.
BIIB
EVP, Chief Medical Officer
2,588
0.0012%
$298.85$773,424+5.94%
2017-04-03SaleBiogen Inc.
BIIB
EVP CMO Neuro & Neurodegenerat
3,962
0.0019%
$274.08$1.09M+6.38%
2017-03-01SaleBiogen Inc.
BIIB
EVP CMO Neuro & Neurodegenerat
1,946
0.0009%
$290.07$564,476-0.13%
2016-02-25SaleBiogen Inc.
BIIB
EVP CMO Neuro & Neurodegenerat
366
0.0002%
$261.90$95,855+8.33%
2016-02-17SaleBiogen Inc.
BIIB
EVP CMO Neuro & Neurodegenerat
1,444
0.0006%
$256.16$369,895+6.55%
Total: 35
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.